Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MACE-ICH feasibility study of mannitol for cerebral oedema after intracerebral haemorrhage
ISRCTN15383301Phase 2Completed
- Sponsor
- Nottingham University Hospitals
- Start
- Feb 2024
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Bronchitol in intracerebral hemorrhage (ICH) (3 arms), sponsored by Nottingham University Hospitals. Primary endpoints: Number of patients screened and eligible, Number of eligible patients recruited and reasons for non-recruitment and 7 more. Started Feb 2024; status: completed.
02
Drugs
Bronchitol
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ISRCTN15383301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15383301.